Fremanezumab ( DrugBank: Fremanezumab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
124	皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症	1
226	間質性膀胱炎（ハンナ型）	1

124. 皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症

臨床試験数 : 12 / 薬物数 : 14 - (DrugBank : 5) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 11

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04334408 (ClinicalTrials.gov)	December 2021	2/4/2020	Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL	A Phase II Double-Blinded Placebo Controlled Individual Subject Stepped Wedge Clinical Trial Evaluat ...	Cadasil;Migraine	Drug: Fremanezumab;Drug: Placebo	Mayo Clinic	NULL	Not yet recruiting	18 Years	70 Years	All	5	Phase 2	United States

臨床試験数 : 145 / 薬物数 : 156 - (DrugBank : 51) / 標的遺伝子数 : 64 - 標的パスウェイ数 : 146

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04447729 (ClinicalTrials.gov)	October 15, 2020	10/6/2020	A Study to Test if FremanezumabReduces Pain in Patients With Interstitial Cystitis-Bladder Pain Synd ...	A Multicenter, Open-label Pilot Study of the Efficacy and Safety of Fremanezumabfor Treatment of Fem ...	Interstitial Cystitis	Drug: fremanezumab	Teva Branded Pharmaceutical Products R&D, Inc.	NULL	Withdrawn	18 Years	N/A	Female	0	Phase 2	NULL